Drug regulation and innovation: Empirical evidence and policy options
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | Undetermined |
| Published: |
Washington, D.C.
American Enterprise Inst. for Public Policy Research
1980
|
| Edition: | 2.print. |
| Series: | Evaluative studies.
28. |
| Subjects: | |
| Physical Description: | 82 S. graph. Darst. |
| ISBN: | 0844732176 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV006097957 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 921030s1980 d||| |||| 00||| und d | ||
| 020 | |a 0844732176 |9 0-8447-3217-6 | ||
| 035 | |a (OCoLC)255924700 | ||
| 035 | |a (DE-599)BVBBV006097957 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-703 | ||
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 100 | 1 | |a Grabowski, Henry G. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Drug regulation and innovation |b Empirical evidence and policy options |
| 250 | |a 2.print. | ||
| 264 | 1 | |a Washington, D.C. |b American Enterprise Inst. for Public Policy Research |c 1980 | |
| 300 | |a 82 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Evaluative studies. |v 28. | |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 830 | 0 | |a Evaluative studies. |v 28. |w (DE-604)BV002790003 |9 28 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003851413 | ||
Record in the Search Index
| _version_ | 1804120322132148224 |
|---|---|
| any_adam_object | |
| author | Grabowski, Henry G. |
| author_facet | Grabowski, Henry G. |
| author_role | aut |
| author_sort | Grabowski, Henry G. |
| author_variant | h g g hg hgg |
| building | Verbundindex |
| bvnumber | BV006097957 |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)255924700 (DE-599)BVBBV006097957 |
| discipline | Wirtschaftswissenschaften |
| edition | 2.print. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01190nam a2200361 cb4500</leader><controlfield tag="001">BV006097957</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921030s1980 d||| |||| 00||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844732176</subfield><subfield code="9">0-8447-3217-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)255924700</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006097957</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Grabowski, Henry G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug regulation and innovation</subfield><subfield code="b">Empirical evidence and policy options</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2.print.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">American Enterprise Inst. for Public Policy Research</subfield><subfield code="c">1980</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">82 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Evaluative studies.</subfield><subfield code="v">28.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Evaluative studies.</subfield><subfield code="v">28.</subfield><subfield code="w">(DE-604)BV002790003</subfield><subfield code="9">28</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003851413</subfield></datafield></record></collection> |
| geographic | USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV006097957 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:40:14Z |
| institution | BVB |
| isbn | 0844732176 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003851413 |
| oclc_num | 255924700 |
| open_access_boolean | |
| owner | DE-703 |
| owner_facet | DE-703 |
| physical | 82 S. graph. Darst. |
| publishDate | 1980 |
| publishDateSearch | 1980 |
| publishDateSort | 1980 |
| publisher | American Enterprise Inst. for Public Policy Research |
| record_format | marc |
| series | Evaluative studies. |
| series2 | Evaluative studies. |
| spelling | Grabowski, Henry G. Verfasser aut Drug regulation and innovation Empirical evidence and policy options 2.print. Washington, D.C. American Enterprise Inst. for Public Policy Research 1980 82 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Evaluative studies. 28. Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittelmarkt (DE-588)4003131-7 s DE-604 Evaluative studies. 28. (DE-604)BV002790003 28 |
| spellingShingle | Grabowski, Henry G. Drug regulation and innovation Empirical evidence and policy options Evaluative studies. Arzneimittelmarkt (DE-588)4003131-7 gnd |
| subject_GND | (DE-588)4003131-7 (DE-588)4078704-7 |
| title | Drug regulation and innovation Empirical evidence and policy options |
| title_auth | Drug regulation and innovation Empirical evidence and policy options |
| title_exact_search | Drug regulation and innovation Empirical evidence and policy options |
| title_full | Drug regulation and innovation Empirical evidence and policy options |
| title_fullStr | Drug regulation and innovation Empirical evidence and policy options |
| title_full_unstemmed | Drug regulation and innovation Empirical evidence and policy options |
| title_short | Drug regulation and innovation |
| title_sort | drug regulation and innovation empirical evidence and policy options |
| title_sub | Empirical evidence and policy options |
| topic | Arzneimittelmarkt (DE-588)4003131-7 gnd |
| topic_facet | Arzneimittelmarkt USA |
| volume_link | (DE-604)BV002790003 |
| work_keys_str_mv | AT grabowskihenryg drugregulationandinnovationempiricalevidenceandpolicyoptions |